The effects of low-ratio n-6/n-3 PUFA on biomarkers of inflammation: a systematic review and meta-analysis

Yali Wei,Yan Meng,Na Li,Qian Wang,Liyong Chen
DOI: https://doi.org/10.1039/d0fo01976c
2021-01-01
Abstract:The purpose of the systematic review and meta-analysis was to determine if low-ratio n-6/n-3 long-chain polyunsaturated fatty acid (PUFA) supplementation affects serum inflammation markers based on current studies.
biochemistry & molecular biology,food science & technology
What problem does this paper attempt to address?
This paper aims to explore whether low - ratio n - 6/n - 3 polyunsaturated fatty acid (PUFA) supplementation can affect the levels of inflammatory markers in serum. Specifically, the research objective is to determine through systematic review and meta - analysis whether low - ratio n - 6/n - 3 long - chain polyunsaturated fatty acid (PUFA) supplementation in current studies can reduce the levels of inflammatory markers in serum, such as tumor necrosis factor - α (TNF - α), interleukin 6 (IL - 6) and C - reactive protein (CRP). ### Research Background The inflammatory response is an important part of the human immune system. When the body is stimulated externally, a large number of inflammatory cells will be produced and inflammatory factors will be secreted. Although a moderate inflammatory response helps to resist pathogens, long - term chronic inflammation is considered to be the basic pathological state of many chronic diseases. Inflammatory cells will secrete excessive inflammatory mediators, such as TNF - α, IL - 6 and CRP, and the long - term presence of these mediators in the body may lead to many chronic diseases and even cancer. In recent years, ω - 6 fatty acids (n - 6 fatty acids) and ω - 3 fatty acids (n - 3 fatty acids), as important members of polyunsaturated fatty acids (PUFA), have received extensive attention. Many studies have shown that EPA and DHA have anti - inflammatory effects and can promote the resolution of inflammation. However, there are controversies among different studies regarding the impact of ω - 3 fatty acids on inflammatory markers. ### Research Purpose The main purpose of this paper is to explore through systematic review and meta - analysis whether low - ratio n - 6/n - 3 PUFA supplementation can significantly reduce the levels of inflammatory markers in serum, especially TNF - α and IL - 6, as well as the impact on CRP. ### Methods Researchers systematically searched relevant randomized controlled trials (RCTs) in the PubMed, Embase and Cochrane Library databases as of July 2020 to evaluate the impact of low - ratio n - 6/n - 3 PUFA supplementation on inflammatory markers. Data were summarized using the standardized mean difference (SMD) and 95% confidence interval (95% CI), and a P - value ≤ 0.05 was considered statistically significant. ### Results A total of 31 RCTs were included in the meta - analysis. The results showed that low - ratio n - 6/n - 3 PUFA supplementation significantly reduced the levels of TNF - α (SMD = - 0.270; 95% CI: - 0.433, - 0.106; P = 0.001) and IL - 6 (SMD = - 0.153; 95% CI: - 0.260, - 0.045; P = 0.005) in serum, but had no significant impact on the CRP level (SMD = - 0.027; 95% CI: - 0.189, 0.135; P = 0.741). ### Conclusions Low - ratio n - 6/n - 3 PUFA supplementation can significantly reduce the levels of TNF - α and IL - 6 in serum, but has no significant impact on the CRP level. This finding is of great significance for understanding how the ratio of n - 6 and n - 3 fatty acids affects the inflammatory response, and also provides new ideas for the prevention and treatment of inflammation - related diseases.